Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Miyata, Toshio ^a   Sugiyama, Satoshi ^b   Suzuki, Daisuke ^b   Inagi, Reiko ^b   Kurokawa, Kiyoshi ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Advanced glycation end products; Advanced lipoxidation end product; Diabetes; Oxidative protein damage; Reactive carbonyl compound

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DRUG DERIVATIVE; LYSINE; MALONALDEHYDE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; 4 HYDROXYNONENAL; CARBOHYDRATE; CARBONYL DERIVATIVE; CELL PROTEIN; LIPID; LYSINE DERIVATIVE; PENTOSIDINE;

ANIMAL; ARTICLE; CARBOHYDRATE METABOLISM; CELL CULTURE; CHEMISTRY; CYTOLOGY; DIABETIC NEPHROPATHY; GLOMERULUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIPID PEROXIDATION; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; RAT; AUTOOXIDATION; CELLULAR DISTRIBUTION; CONFERENCE PAPER; GLYCATION; HUMAN TISSUE; HYPERGLYCEMIA; MESANGIUM CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

ANIMALS; CARBOHYDRATE METABOLISM; CELLS, CULTURED; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; LIPID METABOLISM; LIPID PEROXIDATION; LYSINE; MALONDIALDEHYDE; OXIDATION-REDUCTION; RATS;

EID: 0032973663     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. DYER DG, DUNN JA, THORPE SR, BAILIE KE, LYONS TJ, MCCANCE DR, BAYNES JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469, 1993
2. SUGIYAMA S, MIYATA T, UEDA Y, TANAKA H, MAEDA K, KAWASHIMA S, VAN YPERSELE DE STRIHOU C, KUROKAWA K: Plasma level of pentosidine, an advanced glycation end product, in diabetic patients. J Am Soc Nephrol 9:1681-1688, 1998
3. MCCANCE DR, DYER DG, DUNN JA, BAILIE KE, THORPE SR, BAYNES JW, LYONS TJ: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470-2478, 1993
4. HORIE K, MIYATA T, MAEDA K, MIYATA S, SUGIYAMA S, SAKAI H, VAN YPERSELE DE STRIHOU C, MONNIER VM, WITZTUM JL, KUROKAWA K: Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J Clin Invest 100:2995-3004, 1997
5. MIYATA T, VAN YPERSELE DE STRIHOU C, KUROKAWA K, BAYNES JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55:389-399, 1999
6. SKOLNIK EY, YANG Z, MAKITA Z, RADOFF S, KIRSTEIN M, VLASSARA H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodeling and diabetic nephropathy. J Exp Med 174:931-939, 1991
7. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-a and interleukin-1. J Clin Invest 93:521-528, 1994
8. 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J Clin Invest 98:1088-1094, 1996
9. c-Src. J Cell Biochem 72:1-7, 1999